AUM Cardiovascular, Inc.


Contact Marie Johnson
Title CEO
Phone (612) 868-0073


The CADence device is intended for use in patients with chest pain and two or more coronary risk factors. Currently in pivotal testing to prove non-inferiority to a nuclear stress test, CADence promises to change the way stress testing is performed. CE Marking is expected in August 2014 and FDA approval in September 2015.